Page 129 - GTM-4-1
P. 129

Global Translational Medicine                                          AA amyloidosis in rheumatoid arthritis




            Table 6. Prevalence and mortality of sAAa in rheumatoid arthritis autopsy patients: Impact of sAAa and giAAa on lethal
            outcomes 42
            References               Year of publication  Autopsy, n  Prevalence of sAAa, n (%)  Mortality of sAAa, n/N (%)
            Bayles 53                     1943            23               ND                   3/23 (13.0)
            Baggenstoss and Rosenberg 54  1943            30               2 (6.6)               1/30 (3.3)
            Rosenberg and Baggenstoss5 5   1943           30               2 (6.6)               1/30 (3.3)
            Young and Schwedel 56         1944            33              5 (15.2)               0/33 (0)
            Unger et al. 57               1948            58               4 (6.9)                 ND
            Teilum and Lindahl 58         1954            28              17 (60.7)             7v28 (25.0)
            Gedda 59                      1955            45              11 (24.4)             9/45 (20.0)
            Sinclair and Cruickshank 60   1956            16              4 (25.0)               0/16 (0)
            Missen and Tailor 61          1956            47              8 (17.0)               4/47 (8.5)
            Lebowitz 62                   1963            62              6 (10.0)                 ND
            Sokoloff 63                   1964            19               0 (0)                 0/19 (0)
            Cohen 4                       1968            42              11 (26)                  ND
            Karten 64                     1969            95              1 (1.05)                 ND
            Gritsman 65                   1969            15              6 (40.0)                 ND
            Ozdemir et al. 66             1971            47               1 (2.1)                 ND
            Gardner 67                    1972            142            17 (11.97)                ND
            Püschel 68                    1973            143             15 (10.5)                ND
            Vroninks et al. 69            1973            62              3 (4.84)               0/62 (0)
            Hajzok et al. 70              1976            16              7 (43.7)                 ND
            Eulderink 71                  1976            111              ND                   6/111 (5.4)
            Rainer et al. 72              1978            79               ND                    4/79 (5.0)
            a Boers et al. 73             1987            132             14 (10.6)                ND
            Bély 74                       1993            161             34 (21.1)             17/161 (11)
            Suzuki et al. 75              1994            81              17 (21.0)              6/81 (7.4)
            b Bély and Apáthy 76          2006            234             48 (20.5)             20/234 (8.5)
            Notes: (i) Amyloid deposits were identified using various staining methods with different specificity and sensitivity, including toluidine blue, crystal
            violet, Syrius red, and Congo red staining using Romhányi’s,  Bély and Apáthy’s Congo red method,  Bennhold’s,  Puchtler et al., 78
                                                   45
                                                                            46
                                                                                     77
            a Boers et al.  focused exclusively on renal involvement (n=132).
                    73
            (iii)  Bély and Apáthy  did not explicitly report sAAa prevalence and mortality, which were retrospectively determined for this table.
               b
                          76
            Abbreviations: ND: No data; giAAa: Gastrointestinal amyloid A amyloidosis; sAAa: Systemic amyloid A amyloidosis.
            different tissue structures and organs. This deposition   of GI glands, and small veins become involved, marking
            pattern is driven by variations in precursor production,   advanced stages of amyloid deposition. The terminal stage
            which, in turn, is influenced by RA disease activity. 41  is characterized by the involvement of smooth muscle cells
              The prevalence and severity of AA deposits in various   in the GI walls, venules, and nerves.
            organs and tissue structures represent different aspects of   The  progression  of AA  deposition in  medium-sized,
            the same pathological process, which generally progress   small veins, and venules of the GI tract may be influenced
            parallel (Figures 6,7, 9 and 10).                  by stasis and retrograde accumulation of circulating
                                                               precursors (Figure 9). The role of stasis is further supported
              AA deposition begins in the most frequently affected
            structures of the most commonly involved organ. 3,74,79  In the   by the similar deposition patterns observed in the veins of
                                                                                 43
                                                                         41
            GI tract, AA initially accumulates in the walls of arterioles,   the pancreas and liver
            small arteries, and interstitial collagen fibers. As the disease   The  consistent  relationship  between  AA  deposition
            advances, reticulin fibers (collagen III of adipose tissue),   across different tissue structures allows for the approximate
            medium-sized veins and arteries, basement membranes   estimation of amyloid burden in other structures and



            Volume 4 Issue 1 (2025)                        121                              doi: 10.36922/gtm.5325
   124   125   126   127   128   129   130   131   132   133   134